EVERSANA

Articles by EVERSANA

You Can Build AI In-House. But Should You?

May 22nd 2026

AI Doesn’t Drive Better Outcomes. Better Systems Do

May 22nd 2026

AI Doesn’t Drive Better Outcomes. Better Systems Do

The Shift Pharma Can’t Afford to Miss: From AI Experimentation to Execution

May 22nd 2026

IDN Trends, Insights and Strategies Every Manufacturer Should Know

IDN Trends, Insights and Strategies Every Manufacturer Should Know

July 18th 2024

Webcasts

Webinar Date/Time: Thu, Aug 8, 2024 1:00 PM EDT

There’s a New Way to Omnichannel: Orchestrating Experiences to Drive Sales, Savings and Satisfaction

There’s a New Way to Omnichannel: Orchestrating Experiences to Drive Sales, Savings and Satisfaction

October 13th 2023

Webcasts

Webinar Date/Time: Wed, Nov 1, 2023 11:00 AM EDT

Driving Patient-First Affordability in Seconds, Not Days: Accelerating Time to Therapy

Driving Patient-First Affordability in Seconds, Not Days: Accelerating Time to Therapy

September 18th 2023

Webcasts

Webinar Date/Time: Thu, Oct 12, 2023 2:00 PM EDT

Living Up to Its Promise: Can Omnichannel Deliver the ROI Pharma Needs to Keep Investing?

Living Up to Its Promise: Can Omnichannel Deliver the ROI Pharma Needs to Keep Investing?

February 17th 2023

Webcasts

Webinar Date/Time: Mon, Mar 13, 2023 11:00 AM EDT

Latest Updated Articles

AI Doesn’t Drive Better Outcomes. Better Systems Do
May 22nd 2026
There’s a New Way to Omnichannel: Orchestrating Experiences to Drive Sales, Savings and Satisfaction
October 13th 2023

Trending on PharmExec

Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill

Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics

New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report

As Peptide Rulemaking Stalls, FDA Enforcement Moves Forward

Pharmaceutical Executive Daily: Peptide Ruling Stalls